These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Phage "delay" towards enhancing bacterial escape from biofilms: a more comprehensive way of viewing resistance to bacteriophages. Abedon ST AIMS Microbiol; 2017; 3(2):186-226. PubMed ID: 31294157 [TBL] [Abstract][Full Text] [Related]
6. Big Impact of the Tiny: Bacteriophage-Bacteria Interactions in Biofilms. Hansen MF; Svenningsen SL; Røder HL; Middelboe M; Burmølle M Trends Microbiol; 2019 Sep; 27(9):739-752. PubMed ID: 31128928 [TBL] [Abstract][Full Text] [Related]
8. Ecology and Evolutionary Biology of Hindering Phage Therapy: The Phage Tolerance vs. Phage Resistance of Bacterial Biofilms. Abedon ST Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830158 [TBL] [Abstract][Full Text] [Related]
9. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713 [No Abstract] [Full Text] [Related]
10. Bacteriophages and their enzymes in biofilm control. Chan BK; Abedon ST Curr Pharm Des; 2015; 21(1):85-99. PubMed ID: 25189866 [TBL] [Abstract][Full Text] [Related]
11. Phage mobility is a core determinant of phage-bacteria coexistence in biofilms. Simmons EL; Drescher K; Nadell CD; Bucci V ISME J; 2018 Feb; 12(2):531-543. PubMed ID: 29125597 [TBL] [Abstract][Full Text] [Related]
12. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776 [TBL] [Abstract][Full Text] [Related]
13. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections. Maszewska A; Zygmunt M; Grzejdziak I; Różalski A J Appl Microbiol; 2018 Nov; 125(5):1253-1265. PubMed ID: 29924909 [TBL] [Abstract][Full Text] [Related]
14. Biofilm control with natural and genetically-modified phages. Motlagh AM; Bhattacharjee AS; Goel R World J Microbiol Biotechnol; 2016 Apr; 32(4):67. PubMed ID: 26931607 [TBL] [Abstract][Full Text] [Related]
15. Disruption of Biofilm by Bacteriophages in Clinically Relevant Settings. Kovacs CJ; Rapp EM; McKenzie SM; Mazur MZ; Mchale RP; Brasko B; Min MY; Burpo FJ; Barnhill JC Mil Med; 2024 May; 189(5-6):e1294-e1302. PubMed ID: 37847552 [TBL] [Abstract][Full Text] [Related]
16. Current review-The rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections. Akanda ZZ; Taha M; Abdelbary H J Orthop Res; 2018 Apr; 36(4):1051-1060. PubMed ID: 28971508 [TBL] [Abstract][Full Text] [Related]
17. How Good are Bacteriophages as an Alternative Therapy to Mitigate Biofilms of Nosocomial Infections. Singh A; Padmesh S; Dwivedi M; Kostova I Infect Drug Resist; 2022; 15():503-532. PubMed ID: 35210792 [TBL] [Abstract][Full Text] [Related]
18. The use of phages for the removal of infectious biofilms. Azeredo J; Sutherland IW Curr Pharm Biotechnol; 2008 Aug; 9(4):261-6. PubMed ID: 18691087 [TBL] [Abstract][Full Text] [Related]
19. Investigating the biocontrol and anti-biofilm potential of a three phage cocktail against Cronobacter sakazakii in different brands of infant formula. Endersen L; Buttimer C; Nevin E; Coffey A; Neve H; Oliveira H; Lavigne R; O'Mahony J Int J Food Microbiol; 2017 Jul; 253():1-11. PubMed ID: 28460269 [TBL] [Abstract][Full Text] [Related]